- Erratum
- Open Access
- Published:
Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer
Breast Cancer Research volume 19, Article number: 17 (2017)
Erratum
In the version of this article that was published on PubMed [1] the author’s name “Mark A. Dane” was formatted incorrectly in the XML mark up and therefore appeared incorrectly on PubMed. In the XML mark up, the middle initial “A” was added as a Particle when it should have been included as a Given Name. Due to this error, the author’s name was incorrectly formatted in PubMed as “A Dane M” and not as “Dane MA”. The author’s name is correct on the BioMed Central website. The author's name in the XML of the original article [1] has been updated accordingly.
Reference
Hu Z, Mao JH, Curtis C, Huang G, Gu S, Heiser L, et al. Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer. Breast Cancer Research. 2016;18:70. doi:10.1186/s13058-016-0728-y.
Author information
Authors and Affiliations
Corresponding authors
Additional information
The online version of the original article can be found under doi:10.1186/s13058-016-0728-y.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Hu, Z., Mao, JH., Curtis, C. et al. Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer. Breast Cancer Res 19, 17 (2017). https://doi.org/10.1186/s13058-017-0809-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13058-017-0809-6